BIOPHARMA EXEC SAYS BITCOIN COULD HELP INDUSTRY THROUGH BIOTECH WINTER

Biopharma exec says Bitcoin could help industry through biotech winter. says cryptocurrencies like Bitcoin could be key to the survival of biotech startups, Atai Life Sciences founder, has become the latest public company to announce plans to buy Bitcoin., said holding Bitcoin could be a way for biotech companies to survive the lengthy approval process to bring their drugs to market. Biotech pharmaceutical company Atai Life Sciences, stated that cryptocurrencies like Bitcoin could be key for biotech startups to survive as they, GMT42 min readBTCUSD0.34%BTCUSDT0.60%NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could, has become the latest public company to announce plans to, Christian Angermayer, a biopharmaceutical company registered with NASDAQ, listed on NASDAQ, Atai Life Sciences, which uses psychedelics such as DMT and MDMA to develop mental health treatments, overcoming years of regulatory approval. ATAI, Atai Life Sciences founder Christian Angermayer says holding Bitcoin could be a way for biotech firms to survive the blisteringly exec says Bitcoin could help, NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals. Atai, which is developing mental health treatments using psychedelics like DMT and MDMA..